Paper24136146
Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer.
Goeppert B and 13 others. Br J Cancer, 2013. Cited by 229 papers, by iCite.
Cite this record
ConductScience Library. Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer. Papers, record 24136146. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24136146
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Biliary Tract Neoplasms | Major topic |
| Lymphocytes, Tumor-Infiltrating | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| CD4-Positive T-Lymphocytes | |
| CD8-Positive T-Lymphocytes | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Prognosis | |
| Survival Analysis | |
| Tissue Array Analysis |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16730260 | Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. | Adv Immunol | 2006 | https://conductscience.org/library/papers/16730260 | PubMed |
| 2 | 19018089 | Phase I/II study of ipilimumab for patients with metastatic melanoma. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/19018089 | PubMed |
| 3 | 18837092 | Characterization of hepatic progenitors from human fetal liver during second trimester. | World J Gastroenterol | 2008 | https://conductscience.org/library/papers/18837092 | PubMed |
| 4 | 17312132 | Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. | J Immunol | 2007 | https://conductscience.org/library/papers/17312132 | PubMed |
| 5 | 18408926 | Molecular mechanisms of MHC class I abnormalities and APM components in human tumors. | Cancer Immunol Immunother | 2008 | https://conductscience.org/library/papers/18408926 | PubMed |
| 6 | 22271564 | Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. | Hepatology | 2012 | https://conductscience.org/library/papers/22271564 | PubMed |
| 7 | 11003620 | Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance. | Hepatology | 2000 | https://conductscience.org/library/papers/11003620 | PubMed |
| 8 | 17404089 | Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17404089 | PubMed |
| 9 | 21245428 | Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21245428 | PubMed |
| 10 | 14756433 | Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response. | J Surg Oncol | 2003 | https://conductscience.org/library/papers/14756433 | PubMed |
| 11 | 21483002 | Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21483002 | PubMed |
| 12 | 15032581 | The three Es of cancer immunoediting. | Annu Rev Immunol | 2004 | https://conductscience.org/library/papers/15032581 | PubMed |
| 13 | 20869097 | Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer. | Hum Pathol | 2010 | https://conductscience.org/library/papers/20869097 | PubMed |
| 14 | 17143936 | Colon cancer and the immune system: the role of tumor invading T cells. | World J Gastroenterol | 2006 | https://conductscience.org/library/papers/17143936 | PubMed |
| 15 | 16982773 | HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker. | Cancer Res | 2006 | https://conductscience.org/library/papers/16982773 | PubMed |
| 16 | 22446942 | Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma. | Am J Surg Pathol | 2012 | https://conductscience.org/library/papers/22446942 | PubMed |
| 17 | 19577568 | Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. | Gastroenterology | 2009 | https://conductscience.org/library/papers/19577568 | PubMed |
| 18 | 22658128 | Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22658128 | PubMed |
| 19 | 21255410 | The immunoregulatory mechanisms of carcinoma for its survival and development. | J Exp Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21255410 | PubMed |
| 20 | 12529460 | Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12529460 | PubMed |
Cited by164
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 229 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42972179 | Intrahepatic Cholangiocarcinoma Staging and Classification Systems: An Updated Narrative Review. | J Gastrointest Cancer | 2026 | https://conductscience.org/library/papers/42972179 | PubMed |
| 42210182 | Correlation between preoperative T-cell receptor profile characteristics and postoperative pathological stage/treatment response in non-small cell lung cancer: a prospective cohort study. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42210182 | PubMed |
| 42180539 | Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42180539 | PubMed |
| 41899577 | High CD73 Expression Is Associated with Poor Prognosis in Biliary Tract Cancer Through Reduced Stromal Tumor-Infiltrating Lymphocytes. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41899577 | PubMed |
| 41695364 | Hepatic carcinosarcoma: a rare and aggressive case with unusual molecular signature! | Front Oncol | 2026 | https://conductscience.org/library/papers/41695364 | PubMed |
| 41593214 | Multimodal single-cell profiling reveals crosstalk between macrophages and stromal cells in poor prognostic cholangiocarcinoma patients. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/41593214 | PubMed |
| 41372578 | Cholangiocarcinoma 2026: status quo, unmet needs and priorities. | Nat Rev Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/41372578 | PubMed |
| 41209549 | Aberrant ALPP Expression Serves as a Prognostic Biomarker and Facilitates Cholangiocarcinoma Progression through Immune Evasion and PI3K-Akt Signaling Activation. | Int J Med Sci | 2025 | https://conductscience.org/library/papers/41209549 | PubMed |
| 40940908 | Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next? | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40940908 | PubMed |
| 40712565 | Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity. | Cancer Cell | 2025 | https://conductscience.org/library/papers/40712565 | PubMed |
| 40529922 | Prognostic factors in gallbladder cancer: a comprehensive systematic review and meta-analysis. | Hepatobiliary Surg Nutr | 2025 | https://conductscience.org/library/papers/40529922 | PubMed |
| 40269603 | Dual aVß8 Integrin and PD-1 Blockade Overcomes TGFβ-Mediated B-Cell Suppression to Enhance Anti-Tumor Immunity. | Neuro Oncol | 2025 | https://conductscience.org/library/papers/40269603 | PubMed |
| 40006012 | Immunomodulatory Effects of Atractylodes lancea in Healthy Volunteers with Dosage Prediction for Cholangiocarcinoma Therapy: A Modelling Approach. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40006012 | PubMed |
| 39941881 | Cross-Talk Between Tumor Cells and Stellate Cells Promotes Oncolytic VSV Activity in Intrahepatic Cholangiocarcinoma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39941881 | PubMed |
| 39845973 | Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints. | Front Immunol | 2024 | https://conductscience.org/library/papers/39845973 | PubMed |
| 39811223 | Exceptional Response to Pembrolizumab Following Durvalumab Failure in a Patient With Microsatellite Instability-High Cholangiocarcinoma. | Cureus | 2024 | https://conductscience.org/library/papers/39811223 | PubMed |
| 39770446 | Modulation of FOXP3 Gene Expression in OVCAR3 Cells Following Rosmarinic Acid and Doxorubicin Exposure. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39770446 | PubMed |
| 39752231 | Bola-Amphiphilic Dendrimer Enhances Imatinib to Target Metastatic Ovarian Cancer via β-Catenin-HRP2 Signaling Axis. | ACS Appl Mater Interfaces | 2025 | https://conductscience.org/library/papers/39752231 | PubMed |
| 39660136 | Research hotspots and trends in immunotherapy for cholangiocarcinoma: a bibliometric analysis (2014-2023). | Front Immunol | 2024 | https://conductscience.org/library/papers/39660136 | PubMed |
| 39468006 | Proteomic profiling reveals CEACAM6 function in driving gallbladder cancer aggressiveness through integrin receptor, PRKCD and AKT/ERK signaling. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/39468006 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24136146
GET https://conductscience.org/api/papers/v1/24136146/references?page=2